Results
25
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
25 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MEDCL | €17.20 | -3.9% | 179.2% | €500.3m | €22.45 | PS41.9x | E92.2% | n/a | Pharmaceuticals & Biotech | ||
VU | €137.80 | -0.3% | 28.3% | €2.2b | €192.67 | PS2.7x | E84.2% | 0.2% | Tech | ||
FDE | €26.90 | 10.7% | -40.2% | €141.9m | €51.67 | PE14.6x | E32.5% | n/a | Energy | ||
ADOC | €8.33 | 4.5% | -1.2% | €126.9m | €6.30 | PS35.3x | E64.0% | n/a | Pharmaceuticals & Biotech | ||
ALMUN | €0.66 | -24.8% | -46.2% | €7.3m | €1.30 | PS0.4x | E174.1% | n/a | Tech | ||
AELIS | €2.96 | -0.7% | -78.0% | €38.1m | €14.20 | PS3.7x | E33.8% | n/a | Pharmaceuticals & Biotech | ||
ALCUR | €5.52 | 4.5% | 121.7% | €30.9m | €8.75 | PE11.1x | E26.6% | n/a | Capital Goods | ||
OVH | €8.46 | -0.3% | 5.5% | €1.6b | €9.64 | PS1.6x | E91.5% | n/a | Software | ||
ALSTI | €22.00 | -0.9% | n/a | €114.4m | €33.73 | PE22.7x | E21.9% | 0.9% | Capital Goods | ||
ALSMA | €2.45 | -4.7% | 2.9% | €13.2m | €5.80 | PS1.9x | E103.8% | n/a | Healthcare | ||
ALLIX | €10.60 | 1.3% | 7.1% | €70.2m | €13.50 | PS2x | E116.8% | n/a | Software | ||
ALECP | €0.39 | -0.8% | -10.0% | €48.5m | €0.40 | PE53.9x | E86.8% | 0% | Media | ||
ATEME | €4.29 | 2.1% | -35.2% | €49.3m | €5.65 | PS0.5x | E119.6% | n/a | Tech | ||
ALICA | €8.00 | 3.6% | -27.3% | €63.4m | €11.50 | PE12.5x | E31.6% | 2.5% | Tech | ||
ALCIS | €8.86 | -1.3% | -2.6% | €69.0m | €13.00 | PE26.6x | E41.0% | 1.8% | Commercial Services | ||
AURE | €6.16 | -4.9% | 20.8% | €57.7m | €7.00 | PS0.2x | E98.4% | 0% | Commercial Services | ||
LSS | €26.95 | -2.7% | -4.3% | €1.0b | €33.64 | PE33.2x | E30.6% | 1.3% | Software | ||
GUI | €6.48 | -2.7% | -7.0% | €95.8m | €8.85 | PE15.2x | E32.2% | 0% | Tech | ||
ALESK | €260.00 | 0.2% | 86.8% | €1.5b | €267.86 | PE92.1x | E26.7% | 0.3% | Software | ||
ALOKW | €5.14 | 6.0% | -74.9% | €43.0m | €8.50 | PE9.4x | E28.0% | n/a | Capital Goods | ||
S30 | €0.93 | -2.8% | -59.2% | €99.4m | €1.75 | PS0.09x | E111.8% | n/a | Software | ||
ALBLD | €13.25 | -5.0% | 3.7% | €60.2m | €21.50 | PE13.6x | E21.2% | n/a | Media | ||
ALPAT | €12.30 | -3.9% | 65.1% | €13.6m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
CLA | €1.32 | -2.8% | -7.2% | €74.9m | €3.90 | PS0.2x | E60.0% | n/a | Software |